| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 1.26e-08 | 4 | 213 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 1.26e-08 | 4 | 213 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 6.24e-08 | 5 | 213 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 4.30e-07 | 7 | 213 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 1.52e-06 | 9 | 213 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 2.51e-06 | 10 | 213 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 8.35e-06 | 13 | 213 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 6.44e-05 | 8 | 213 | 3 | GO:0004571 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 1.13e-04 | 2 | 213 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 1.13e-04 | 2 | 213 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 1.36e-04 | 10 | 213 | 3 | GO:0015924 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 2.97e-04 | 55 | 213 | 5 | GO:0008146 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 4.95e-04 | 15 | 213 | 3 | GO:0004559 | |
| GeneOntologyMolecularFunction | mannosidase activity | 6.05e-04 | 16 | 213 | 3 | GO:0015923 | |
| GeneOntologyMolecularFunction | sulfur compound binding | CEP104 INSR SULT1A2 SULT1A1 SULT1A3 PTPRS COL5A1 SULT1A4 PRELP HACL1 HADHA | 7.31e-04 | 323 | 213 | 11 | GO:1901681 |
| GeneOntologyMolecularFunction | protein kinase activity | ERBB2 SPEG RPS6KB2 INSR PRAG1 TTBK1 NEK5 AKT2 WNK4 WNK2 DDR2 RET SGK2 MAP2K1 MAP2K2 CDK4 | 7.42e-04 | 600 | 213 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.68e-04 | 18 | 213 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 MYO9B ATAD5 ABCA8 KIF5C TAP2 VCP DNAH3 SMARCA5 DYNC2H1 MSH2 MTREX ATP2B1 | 9.47e-04 | 441 | 213 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 9.49e-04 | 145 | 213 | 7 | GO:0004713 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.17e-03 | 74 | 213 | 5 | GO:0016782 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.19e-03 | 20 | 213 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | kinase activity | ERBB2 SPEG RPS6KB2 INSR PRAG1 TTBK1 NEK5 AK2 AKT2 WNK4 WNK2 DDR2 RET SGK2 PALS1 MAP2K1 MAP2K2 CDK4 | 1.44e-03 | 764 | 213 | 18 | GO:0016301 |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 5.48e-08 | 5 | 213 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | sulfation | 2.79e-07 | 27 | 213 | 6 | GO:0051923 | |
| GeneOntologyBiologicalProcess | Schwann cell development | 8.53e-06 | 47 | 213 | 6 | GO:0014044 | |
| GeneOntologyBiologicalProcess | mannoprotein catabolic process | 1.07e-05 | 5 | 213 | 3 | GO:0006058 | |
| GeneOntologyBiologicalProcess | mannoprotein metabolic process | 1.07e-05 | 5 | 213 | 3 | GO:0006056 | |
| GeneOntologyBiologicalProcess | Schwann cell differentiation | 2.15e-05 | 55 | 213 | 6 | GO:0014037 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 2.37e-05 | 17 | 213 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 2.37e-05 | 17 | 213 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 2.37e-05 | 17 | 213 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | ERBB2 RELN CEACAM5 MYO9B INSR MCL1 TTBK1 UBE2L3 NEK5 ARHGEF7 PLCB1 AKT2 PLCL1 CCL16 WNK4 WNK2 PLXNB1 VCP TBC1D30 LRRC38 DDR2 DVL3 NR4A2 MSH2 RET NFAM1 SGK2 PARN MAP2K1 MAP2K2 GPSM1 USP6NL | 2.87e-05 | 1430 | 213 | 32 | GO:0044093 |
| GeneOntologyBiologicalProcess | lamellipodium morphogenesis | 3.02e-05 | 18 | 213 | 4 | GO:0072673 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 3.02e-05 | 18 | 213 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent glycoprotein ERAD pathway | 5.85e-05 | 8 | 213 | 3 | GO:0097466 | |
| GeneOntologyBiologicalProcess | protein deglycosylation involved in glycoprotein catabolic process | 5.85e-05 | 8 | 213 | 3 | GO:0035977 | |
| GeneOntologyBiologicalProcess | protein alpha-1,2-demannosylation | 5.85e-05 | 8 | 213 | 3 | GO:0036508 | |
| GeneOntologyBiologicalProcess | protein demannosylation | 5.85e-05 | 8 | 213 | 3 | GO:0036507 | |
| GeneOntologyBiologicalProcess | mannose trimming involved in glycoprotein ERAD pathway | 5.85e-05 | 8 | 213 | 3 | GO:1904382 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | ERBB2 RELN CEACAM5 MYO9B INSR MCL1 TTBK1 UBE2L3 NEK5 ARHGEF7 AKT2 CCL16 WNK4 PLXNB1 VCP TBC1D30 DDR2 DVL3 NR4A2 MSH2 RET PARN MAP2K1 MAP2K2 USP6NL | 6.36e-05 | 1028 | 213 | 25 | GO:0043085 |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 8.39e-05 | 23 | 213 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 8.71e-05 | 9 | 213 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 1.17e-04 | 74 | 213 | 6 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 1.17e-04 | 74 | 213 | 6 | GO:0006584 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | BBS1 DTNBP1 KATNIP TAC3 KIF5C WASF1 DNAH3 DYNC2H1 LRPPRC GAS2L2 IFT88 DYNC2LI1 DNAH17 DNAI4 MAP2K1 | 1.98e-04 | 493 | 213 | 15 | GO:0007018 |
| GeneOntologyBiologicalProcess | transport along microtubule | BBS1 DTNBP1 KIF5C WASF1 DYNC2H1 LRPPRC IFT88 DYNC2LI1 MAP2K1 | 2.16e-04 | 197 | 213 | 9 | GO:0010970 |
| GeneOntologyBiologicalProcess | response to glycoprotein | 2.23e-04 | 12 | 213 | 3 | GO:1904587 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 2.65e-04 | 121 | 213 | 7 | GO:0006576 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.88e-04 | 13 | 213 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 2.88e-04 | 13 | 213 | 3 | GO:0038133 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | BBS1 DTNBP1 KATNIP KIF5C WASF1 DYNC2H1 LRPPRC IFT88 DYNC2LI1 MAP2K1 | 3.14e-04 | 253 | 213 | 10 | GO:0099111 |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 3.16e-04 | 3 | 213 | 2 | GO:0048252 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ERBB2 RELN MYO9B DTNBP1 ARHGEF7 PTPRS MYPN AFDN KIF5C SULT4A1 WASF1 PLXNB1 DVL3 NR4A2 LAMA3 RET WASF2 MAP2K1 MAP2K2 CUX1 | 3.37e-04 | 819 | 213 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle G2/M phase transition | 3.58e-04 | 33 | 213 | 4 | GO:1902751 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 3.63e-04 | 14 | 213 | 3 | GO:0038129 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ERBB2 RELN MYO9B DTNBP1 ARHGEF7 PTPRS MYPN AFDN KIF5C SULT4A1 WASF1 PLXNB1 DVL3 NR4A2 LAMA3 RET WASF2 MAP2K1 MAP2K2 CUX1 | 3.76e-04 | 826 | 213 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | intraciliary retrograde transport | 4.51e-04 | 15 | 213 | 3 | GO:0035721 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 8.73e-05 | 9 | 216 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | tight junction | 1.01e-04 | 139 | 216 | 8 | GO:0070160 | |
| GeneOntologyCellularComponent | dynein complex | 2.36e-04 | 54 | 216 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | apical junction complex | 2.44e-04 | 158 | 216 | 8 | GO:0043296 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.64e-04 | 14 | 216 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | bicellular tight junction | 4.31e-04 | 131 | 216 | 7 | GO:0005923 | |
| GeneOntologyCellularComponent | endoplasmic reticulum quality control compartment | 6.65e-04 | 17 | 216 | 3 | GO:0044322 | |
| HumanPheno | Left ventricular hypertrophy | 1.10e-05 | 124 | 75 | 10 | HP:0001712 | |
| Domain | Carb-bd-like_fold | 1.13e-06 | 8 | 214 | 4 | IPR013784 | |
| Domain | DUF2012 | 5.88e-06 | 4 | 214 | 3 | PF09430 | |
| Domain | LRRC37AB_C | 5.88e-06 | 4 | 214 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 5.88e-06 | 4 | 214 | 3 | PF14914 | |
| Domain | DUF2012 | 5.88e-06 | 4 | 214 | 3 | IPR019008 | |
| Domain | LRRC37_N | 5.88e-06 | 4 | 214 | 3 | IPR032754 | |
| Domain | LRRC37 | 5.88e-06 | 4 | 214 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 5.88e-06 | 4 | 214 | 3 | IPR015753 | |
| Domain | CarboxyPept_regulatory_dom | 1.10e-05 | 13 | 214 | 4 | IPR014766 | |
| Domain | - | 1.10e-05 | 13 | 214 | 4 | 2.60.40.1120 | |
| Domain | CarboxyPept-like_regulatory | 3.55e-05 | 17 | 214 | 4 | IPR008969 | |
| Domain | Glyco_hydro_47 | 5.02e-05 | 7 | 214 | 3 | PF01532 | |
| Domain | - | 5.02e-05 | 7 | 214 | 3 | 1.50.10.50 | |
| Domain | Sulfotransfer_1 | 5.32e-05 | 36 | 214 | 5 | PF00685 | |
| Domain | Sulfotransferase_dom | 5.32e-05 | 36 | 214 | 5 | IPR000863 | |
| Domain | Glyco_hydro_47 | 7.96e-05 | 8 | 214 | 3 | IPR001382 | |
| Domain | Ecm29/Gcn1 | 1.31e-04 | 2 | 214 | 2 | IPR026827 | |
| Domain | Prot_kinase_dom | ERBB2 SPEG RPS6KB2 INSR PRAG1 TTBK1 NEK5 AKT2 WNK4 WNK2 DDR2 RET SGK2 MAP2K1 MAP2K2 CDK4 | 1.71e-04 | 489 | 214 | 16 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | ERBB2 SPEG RPS6KB2 INSR PRAG1 TTBK1 NEK5 AKT2 WNK4 WNK2 DDR2 RET SGK2 MAP2K1 MAP2K2 CDK4 | 1.88e-04 | 493 | 214 | 16 | PS50011 |
| Domain | HEAT | 2.16e-04 | 48 | 214 | 5 | PF02985 | |
| Domain | P-loop_NTPase | ABCA1 MYO9B ATAD5 ABCA8 TUFM SULT1A2 SULT1A1 HELZ AK2 KIF5C SULT4A1 TAP2 VCP NLRP8 DNAH3 SMARCA5 DYNC2H1 NOA1 MSH2 PALS1 DYNC2LI1 MTREX | 3.07e-04 | 848 | 214 | 22 | IPR027417 |
| Domain | - | ABCA1 ATAD5 ABCA8 TUFM SULT1A2 SULT1A1 HELZ AK2 SULT4A1 TAP2 VCP NLRP8 DNAH3 SMARCA5 DYNC2H1 NOA1 MSH2 PALS1 DYNC2LI1 MTREX | 3.83e-04 | 746 | 214 | 20 | 3.40.50.300 |
| Domain | PLC-beta_CS | 3.89e-04 | 3 | 214 | 2 | IPR009535 | |
| Domain | DMA | 3.89e-04 | 3 | 214 | 2 | IPR005173 | |
| Domain | SCAR/WAVE_fam | 3.89e-04 | 3 | 214 | 2 | IPR028288 | |
| Domain | Nuc_orph_rcpt | 3.89e-04 | 3 | 214 | 2 | IPR003070 | |
| Domain | DMA | 3.89e-04 | 3 | 214 | 2 | PF03474 | |
| Domain | PLC-beta_C | 3.89e-04 | 3 | 214 | 2 | PF08703 | |
| Domain | PLC-beta_C | 3.89e-04 | 3 | 214 | 2 | IPR014815 | |
| Domain | DUF1154 | 3.89e-04 | 3 | 214 | 2 | PF06631 | |
| Domain | HEAT | 5.27e-04 | 58 | 214 | 5 | IPR000357 | |
| Domain | Kinase-like_dom | ERBB2 SPEG RPS6KB2 INSR PRAG1 TTBK1 NEK5 AKT2 WNK4 WNK2 DDR2 RET SGK2 MAP2K1 MAP2K2 CDK4 | 5.35e-04 | 542 | 214 | 16 | IPR011009 |
| Domain | EF-hand_like | 6.10e-04 | 15 | 214 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 6.10e-04 | 15 | 214 | 3 | PF00387 | |
| Domain | PLCYc | 6.10e-04 | 15 | 214 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 6.10e-04 | 15 | 214 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 6.10e-04 | 15 | 214 | 3 | PS50008 | |
| Domain | PI-PLC_fam | 6.10e-04 | 15 | 214 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 6.10e-04 | 15 | 214 | 3 | IPR015359 | |
| Domain | PLC-beta | 7.72e-04 | 4 | 214 | 2 | IPR016280 | |
| Domain | C2 | 7.90e-04 | 131 | 214 | 7 | PF00168 | |
| Domain | PROTEIN_KINASE_ATP | ERBB2 SPEG RPS6KB2 INSR TTBK1 NEK5 AKT2 WNK4 WNK2 RET SGK2 MAP2K1 MAP2K2 CDK4 | 8.68e-04 | 459 | 214 | 14 | PS00107 |
| Domain | S_TKc | SPEG RPS6KB2 PRAG1 TTBK1 NEK5 AKT2 WNK4 WNK2 SGK2 MAP2K1 MAP2K2 CDK4 | 9.27e-04 | 359 | 214 | 12 | SM00220 |
| Domain | C2 | 1.03e-03 | 137 | 214 | 7 | SM00239 | |
| Domain | PI-PLC-X | 1.07e-03 | 18 | 214 | 3 | PF00388 | |
| Domain | PLCXc | 1.07e-03 | 18 | 214 | 3 | SM00148 | |
| Domain | HEAT_REPEAT | 1.25e-03 | 70 | 214 | 5 | PS50077 | |
| Domain | PIPLC_X_DOMAIN | 1.26e-03 | 19 | 214 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 1.26e-03 | 19 | 214 | 3 | IPR000909 | |
| Domain | C2 | 1.27e-03 | 142 | 214 | 7 | PS50004 | |
| Domain | FerI | 1.28e-03 | 5 | 214 | 2 | SM01202 | |
| Domain | FerB | 1.28e-03 | 5 | 214 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 1.28e-03 | 5 | 214 | 2 | IPR012561 | |
| Domain | Ferlin_C | 1.28e-03 | 5 | 214 | 2 | PF16165 | |
| Domain | Ferlin_C | 1.28e-03 | 5 | 214 | 2 | IPR032362 | |
| Domain | FerIin_dom | 1.28e-03 | 5 | 214 | 2 | IPR012968 | |
| Domain | FerI | 1.28e-03 | 5 | 214 | 2 | PF08151 | |
| Domain | FerB | 1.28e-03 | 5 | 214 | 2 | PF08150 | |
| Domain | AAA | 1.37e-03 | 144 | 214 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.37e-03 | 144 | 214 | 7 | IPR003593 | |
| Domain | Protein_kinase_ATP_BS | ERBB2 SPEG RPS6KB2 INSR TTBK1 NEK5 AKT2 RET SGK2 MAP2K1 MAP2K2 CDK4 | 1.47e-03 | 379 | 214 | 12 | IPR017441 |
| Domain | Pkinase | SPEG RPS6KB2 PRAG1 TTBK1 NEK5 AKT2 WNK4 WNK2 SGK2 MAP2K1 MAP2K2 CDK4 | 1.54e-03 | 381 | 214 | 12 | PF00069 |
| Domain | - | 1.61e-03 | 148 | 214 | 7 | 2.60.40.150 | |
| Domain | OSR1_C | 1.90e-03 | 6 | 214 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.90e-03 | 6 | 214 | 2 | IPR024678 | |
| Domain | DM_2 | 2.64e-03 | 7 | 214 | 2 | PS50809 | |
| Domain | DM | 2.64e-03 | 7 | 214 | 2 | SM00301 | |
| Domain | - | 2.64e-03 | 7 | 214 | 2 | 4.10.1040.10 | |
| Domain | Recep_L_domain | 2.64e-03 | 7 | 214 | 2 | PF01030 | |
| Domain | DM_DNA-bd | 2.64e-03 | 7 | 214 | 2 | IPR001275 | |
| Domain | DM | 2.64e-03 | 7 | 214 | 2 | PF00751 | |
| Domain | Furin-like | 2.64e-03 | 7 | 214 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 2.64e-03 | 7 | 214 | 2 | IPR000494 | |
| Domain | DM_1 | 2.64e-03 | 7 | 214 | 2 | PS40000 | |
| Domain | Furin-like_Cys-rich_dom | 2.64e-03 | 7 | 214 | 2 | IPR006211 | |
| Domain | - | 2.64e-03 | 7 | 214 | 2 | 3.80.20.20 | |
| Domain | - | 2.83e-03 | 25 | 214 | 3 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 2.83e-03 | 25 | 214 | 3 | IPR017946 | |
| Domain | Ser/Thr_kinase_AS | SPEG RPS6KB2 TTBK1 NEK5 AKT2 WNK4 WNK2 SGK2 MAP2K1 MAP2K2 CDK4 | 2.83e-03 | 357 | 214 | 11 | IPR008271 |
| Domain | C2_dom | 2.87e-03 | 164 | 214 | 7 | IPR000008 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 7.72e-08 | 5 | 159 | 4 | M47807 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 4.89e-06 | 23 | 159 | 5 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 6.13e-06 | 24 | 159 | 5 | M16289 | |
| Pathway | KEGG_SULFUR_METABOLISM | 1.03e-05 | 13 | 159 | 4 | M18256 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 3.31e-05 | 17 | 159 | 4 | M39483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 5.29e-05 | 19 | 159 | 4 | M47596 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 7.24e-05 | 39 | 159 | 5 | M39905 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 8.03e-05 | 21 | 159 | 4 | M47638 | |
| Pathway | WP_ESTROGEN_METABOLISM | 9.73e-05 | 22 | 159 | 4 | MM15888 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 1.59e-04 | 10 | 159 | 3 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 1.59e-04 | 10 | 159 | 3 | MM14778 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 1.59e-04 | 10 | 159 | 3 | M47644 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | ERBB2 RELN MYO9B ARHGEF7 PLXNB1 DOK1 COL4A4 COL5A1 RET MAP2K1 MAP2K2 | 1.83e-04 | 261 | 159 | 11 | MM15676 |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.17e-04 | 11 | 159 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 2.87e-04 | 12 | 159 | 3 | M47393 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.22e-04 | 115 | 159 | 7 | M9387 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 3.47e-04 | 54 | 159 | 5 | M19818 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 3.87e-04 | 31 | 159 | 4 | M213 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 4.68e-04 | 14 | 159 | 3 | M668 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 4.68e-04 | 14 | 159 | 3 | MM1489 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 5.03e-04 | 89 | 159 | 6 | M39732 | |
| Pubmed | CAPN9 ERBB2 CEACAM5 RPS6KB2 INSR MCL1 SULT1A2 TTBK1 SULT1A1 SULT1A3 UBE2L3 PLCB1 AKT2 PLCB3 PLCL1 WNK4 WNK2 NAPSA SGK2 SULT1A4 ADAMTS6 DNAH17 MAP2K1 MAP2K2 ATP2B1 CDK4 | 1.14e-12 | 730 | 218 | 26 | 34857952 | |
| Pubmed | LRRC37A3 ATAD5 NDUFS2 FER1L6 PLEKHH1 GSE1 PLCB1 RRP7A FER1L5 WASF1 HECTD3 FXR2 DYNC2H1 NBEA NCOR2 RNF2 ADAMTS6 PRELP AATF MAP2K2 ATP2B1 CUX1 NOMO3 RAI1 | 2.86e-12 | 638 | 218 | 24 | 31182584 | |
| Pubmed | SF3A1 TUFM RBM25 HELZ UTP20 AFDN RRP7A GCN1 MVP VCP COL5A1 SMARCA5 FXR2 MSH2 IPO4 ECPAS LRPPRC AATF PARN HADHA MTREX RAI1 | 1.98e-10 | 653 | 218 | 22 | 22586326 | |
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 5.10e-10 | 8 | 218 | 5 | 10594240 | |
| Pubmed | 1.50e-09 | 4 | 218 | 4 | 33414449 | ||
| Pubmed | 1.50e-09 | 4 | 218 | 4 | 8943792 | ||
| Pubmed | 1.50e-09 | 4 | 218 | 4 | 32152050 | ||
| Pubmed | 1.50e-09 | 4 | 218 | 4 | 8288252 | ||
| Pubmed | 1.50e-09 | 4 | 218 | 4 | 25370010 | ||
| Pubmed | 1.50e-09 | 4 | 218 | 4 | 24318996 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 1.50e-09 | 4 | 218 | 4 | 12390022 | |
| Pubmed | 1.50e-09 | 4 | 218 | 4 | 8424956 | ||
| Pubmed | 4.14e-09 | 11 | 218 | 5 | 10720750 | ||
| Pubmed | 4.14e-09 | 11 | 218 | 5 | 11154739 | ||
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 4.14e-09 | 11 | 218 | 5 | 9034160 | |
| Pubmed | 7.47e-09 | 5 | 218 | 4 | 25053625 | ||
| Pubmed | 7.47e-09 | 5 | 218 | 4 | 24802129 | ||
| Pubmed | 7.47e-09 | 5 | 218 | 4 | 11389699 | ||
| Pubmed | 7.47e-09 | 5 | 218 | 4 | 29908303 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 1.14e-08 | 13 | 218 | 5 | 17425406 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ERBB2 INSR SYNPO NDUFS3 PLEKHH1 PTPRS KATNIP CACNA1H KIF5C WNK2 COL5A1 RHBDF2 POLG LAMA3 PPHLN1 ECPAS SHROOM2 SGK2 NCOR2 LRPPRC SIGIRR NEMF VPS41 DIP2C MAP2K2 ATP2B1 CEP170B CUX1 MAN1B1 RAI1 | 1.85e-08 | 1489 | 218 | 30 | 28611215 |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | MYO9B ABCA8 HOXC10 VILL MYPN MVP SMARCA5 TCN2 FXR2 POLG ELP3 NCOR2 CEP170B CUX1 | 1.86e-08 | 321 | 218 | 14 | 32098917 |
| Pubmed | MYO9B SF3A1 INSR NDUFS3 TUFM RBM25 FDPS SVIL AMOTL2 GCN1 MVP VCP SMARCA5 FXR2 DVL3 MSH2 NCOR2 PALS1 LRPPRC RNF2 WASF2 NEMF HADHA MTREX MAP2K1 MAP2K2 CUX1 | 2.38e-08 | 1247 | 218 | 27 | 27684187 | |
| Pubmed | 5.18e-08 | 7 | 218 | 4 | 12438748 | ||
| Pubmed | 5.18e-08 | 7 | 218 | 4 | 9370299 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 1.85e-07 | 9 | 218 | 4 | 23207770 | |
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 1.85e-07 | 9 | 218 | 4 | 9060415 | |
| Pubmed | 1.85e-07 | 9 | 218 | 4 | 8887328 | ||
| Pubmed | 1.85e-07 | 9 | 218 | 4 | 19548878 | ||
| Pubmed | 1.85e-07 | 9 | 218 | 4 | 9177785 | ||
| Pubmed | 1.85e-07 | 9 | 218 | 4 | 9166597 | ||
| Pubmed | 1.85e-07 | 9 | 218 | 4 | 8468045 | ||
| Pubmed | SYNPO ARHGEF7 PTPRS SVIL PLCB1 AFDN PLCL1 KIF5C WASF1 WNK2 FXR2 NBEA CNKSR2 IPO4 NCOR2 PALS1 LRPPRC WASF2 PARN CEP170B CUX1 RAI1 | 2.10e-07 | 963 | 218 | 22 | 28671696 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 9855620 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 36011023 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 2.43e-07 | 3 | 218 | 3 | 8363592 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 12802074 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 8912648 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 30106181 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.43e-07 | 3 | 218 | 3 | 25576386 | |
| Pubmed | SYNPO NDUFS2 NDUFS3 UBE2L3 ARHGEF7 FDPS PLCB1 HELZ AFDN AKT2 WASF1 GCN1 WNK2 VCP MPC2 FXR2 DVL3 NBEA CNKSR2 SHROOM2 PITPNM1 LRPPRC HADHA CEP170B | 2.48e-07 | 1139 | 218 | 24 | 36417873 | |
| Pubmed | CEP104 ERBB2 SYNPO ARHGEF7 FDPS PLCB1 AMOTL2 SYT13 WNK2 PLXNB1 ECPAS TUBGCP6 MTREX EDEM1 USP6NL RAI1 | 2.77e-07 | 529 | 218 | 16 | 14621295 | |
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 3.06e-07 | 10 | 218 | 4 | 11535246 | |
| Pubmed | 3.06e-07 | 10 | 218 | 4 | 7601475 | ||
| Pubmed | 3.47e-07 | 105 | 218 | 8 | 9628581 | ||
| Pubmed | SYNPO ALDH1L1 PTGS2 NDUFS2 NDUFS3 TUFM PTPRS SVIL AFDN PLCL1 KIF5C WASF1 WNK2 VCP MPC2 RBP3 NBEA CNKSR2 ELP3 SHROOM2 PITPNM1 LRPPRC GUCY1A2 HADHA MAP2K1 ATP2B1 CEP170B | 3.72e-07 | 1431 | 218 | 27 | 37142655 | |
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 4.79e-07 | 11 | 218 | 4 | 7613026 | |
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 4.79e-07 | 11 | 218 | 4 | 8954725 | |
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 7.15e-07 | 12 | 218 | 4 | 7706460 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 9.67e-07 | 4 | 218 | 3 | 31833031 | |
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 9267806 | ||
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 22419166 | ||
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 9342439 | ||
| Pubmed | 1.03e-06 | 13 | 218 | 4 | 10585447 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ERAP1 SPEG SF3A1 ACP2 MCL1 EXT2 NDUFS2 NDUFS3 TUFM RBM25 NOMO2 AK2 TAP2 VCP MPC2 NOA1 DDR2 NOMO1 NCOR2 LRPPRC HADHA MTREX ATP2B1 USP6NL NOMO3 MAN1B1 | 1.62e-06 | 1451 | 218 | 26 | 30550785 |
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 1741163 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SF3A1 EXT2 TUFM NAA25 RBM25 TTBK1 UBE2L3 ARHGEF7 PTPRS AFDN KIF5C GCN1 VCP FXR2 EBLN2 CNKSR2 MSH2 IPO4 ECPAS LRPPRC HADHA MTREX EDEM1 CDK4 | 2.05e-06 | 1284 | 218 | 24 | 17353931 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ERBB2 GINM1 ERAP1 EXT2 TM9SF2 NOMO2 PTPRS SVIL UTP20 AK2 SUCO TAP2 PLXNB1 VCP COL4A4 COL5A1 DNAJB4 NOMO1 EDEM3 NETO2 EDEM1 ATP2B1 MAN1B1 | 2.27e-06 | 1201 | 218 | 23 | 35696571 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EXT2 QRICH1 NDUFS2 NDUFS3 TUFM NAA25 TM9SF2 UTP20 GCN1 VCP HECTD3 DYNC2H1 MSH2 IPO4 ECPAS LRPPRC HADHA NOMO3 MAN1B1 CDK4 | 2.35e-06 | 942 | 218 | 20 | 31073040 |
| Pubmed | ERBB2 ERAP1 SYNPO NDUFS2 SVIL AKT2 AMOTL2 TAP2 FXR2 MSH2 ECPAS LRPPRC SMARCD3 HADHA MTREX CDK4 | 2.93e-06 | 634 | 218 | 16 | 34591612 | |
| Pubmed | ABCA1 CYP4A11 ALDH1L1 ABCA8 NDUFS3 SULT1A2 SULT1A1 SULT4A1 TAP2 | 3.96e-06 | 193 | 218 | 9 | 19343046 | |
| Pubmed | TUFM GSE1 ARHGEF7 HELZ AFDN PLCB3 PLXNB1 HECTD3 NOA1 PALS1 WASF2 NEMF PARN MTREX EDEM1 MAN1B1 | 4.01e-06 | 650 | 218 | 16 | 38777146 | |
| Pubmed | 4.29e-06 | 18 | 218 | 4 | 20056724 | ||
| Pubmed | 4.79e-06 | 6 | 218 | 3 | 24126911 | ||
| Pubmed | 5.41e-06 | 19 | 218 | 4 | 26043024 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ERBB2 LRRC37A3 BBS1 NR4A1 GSE1 PLCB1 AP1G2 AMOTL2 SUCO TAP2 DBF4B POLG VPS8 IPO4 PITPNM1 CTDP1 SMARCD3 HACL1 FILIP1L | 6.78e-06 | 925 | 218 | 19 | 28986522 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 MYO9B SPEG PRAG1 PTPRS AP1G2 CACNA1H AKT2 GCN1 WNK2 CRYBG2 RHBDF2 POLG ZNF316 CLDN7 NCOR2 CTDP1 DIP2C CEP170B CYB5R2 RAI1 | 7.19e-06 | 1105 | 218 | 21 | 35748872 |
| Pubmed | 8.27e-06 | 21 | 218 | 4 | 32301970 | ||
| Pubmed | 8.27e-06 | 21 | 218 | 4 | 24603431 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 15121860 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 23401445 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SF3A1 BBS1 DTNBP1 NDUFS2 TM9SF2 NEK5 HELZ AFDN KATNIP KIF5C WASF1 GCN1 MPC2 DYNC2H1 DVL3 DNAJB4 MSH2 IPO4 NOMO1 LRPPRC RNF2 IFT88 CDK4 | 1.07e-05 | 1321 | 218 | 23 | 27173435 |
| Pubmed | SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption. | 1.13e-05 | 120 | 218 | 7 | 37929963 | |
| Pubmed | 1.13e-05 | 120 | 218 | 7 | 27320910 | ||
| Pubmed | Proteomic analysis identifies novel binding partners of BAP1. | 1.16e-05 | 80 | 218 | 6 | 34591877 | |
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | 1.29e-05 | 282 | 218 | 10 | 35007762 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.33e-05 | 8 | 218 | 3 | 15257293 | |
| Pubmed | TUFM GSE1 NOMO2 AP1G2 RRP7A NOMO1 AATF PARN MTREX MAP2K1 NOMO3 | 1.36e-05 | 347 | 218 | 11 | 15231747 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PARVG NDUFS2 NDUFS3 TUFM GSE1 UTP20 PLCB3 AMOTL2 DNAH3 TBC1D30 FXR2 ZNF316 NBEA ECPAS HADHA RAI1 | 1.87e-05 | 736 | 218 | 16 | 29676528 |
| Pubmed | Cell cycle during neuronal migration and neocortical lamination. | 1.98e-05 | 9 | 218 | 3 | 33448039 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.98e-05 | 9 | 218 | 3 | 36261522 | |
| Pubmed | RELN SYNPO QRICH1 PLEKHH1 NAA25 NOMO2 AFDN KIF5C AMOTL2 SULT4A1 MVP VCP POLG DVL3 NR4A2 NBEA CLIC6 IDS SHROOM2 IFT88 NEMF CUX1 | 2.17e-05 | 1285 | 218 | 22 | 35914814 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | ERBB2 PRAG1 AKT2 WNK4 HECTD3 DDR2 RET SGK2 VPS41 DMRTA1 CDK4 | 2.58e-05 | 372 | 218 | 11 | 22939624 |
| Pubmed | CEACAM5 ATAD5 NDUFS2 NDUFS3 TUFM CRYBG1 HELZ UTP20 AFDN RRP7A TBC1D30 NOA1 PPHLN1 IPO4 NOMO1 RNF2 WASF2 GATAD1 AATF PARN MTREX USP6NL CEP170B MAN1B1 | 2.61e-05 | 1497 | 218 | 24 | 31527615 | |
| Pubmed | Abi1 is essential for the formation and activation of a WAVE2 signalling complex. | 2.82e-05 | 10 | 218 | 3 | 15048123 | |
| Pubmed | 2.82e-05 | 10 | 218 | 3 | 23064749 | ||
| Pubmed | 3.13e-05 | 250 | 218 | 9 | 18660489 | ||
| Pubmed | Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy. | 3.15e-05 | 29 | 218 | 4 | 26633882 | |
| Pubmed | 3.22e-05 | 251 | 218 | 9 | 27507650 | ||
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 3.35e-05 | 142 | 218 | 7 | 19851296 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SF3A1 NDUFS2 NDUFS3 TUFM RBM25 TM9SF2 UTP20 AFDN RRP7A GCN1 SMARCA5 DYNC2H1 MSH2 IPO4 ECPAS NOMO1 LRPPRC RNF2 NEMF HADHA MTREX ATP2B1 CDK4 | 3.50e-05 | 1425 | 218 | 23 | 30948266 |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 3.51e-05 | 143 | 218 | 7 | 20198315 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 3.86e-05 | 11 | 218 | 3 | 32820719 | |
| Pubmed | Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. | 3.91e-05 | 2 | 218 | 2 | 9563949 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 15611369 | ||
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 3.91e-05 | 2 | 218 | 2 | 14871892 | |
| Pubmed | Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer. | 3.91e-05 | 2 | 218 | 2 | 29873317 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 12832465 | ||
| Pubmed | Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory. | 3.91e-05 | 2 | 218 | 2 | 23161447 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 32697617 | ||
| Interaction | NR3C1 interactions | LRRC37A3 ATAD5 SF3A1 NR4A1 NDUFS2 TUFM FER1L6 PLEKHH1 GSE1 UBE2L3 SVIL PLCB1 RRP7A FER1L5 WASF1 HECTD3 FXR2 DYNC2H1 NBEA NCOR2 LRPPRC RNF2 ADAMTS6 PRELP AATF HADHA MAP2K2 ATP2B1 CUX1 NOMO3 RAI1 | 4.07e-08 | 974 | 213 | 31 | int:NR3C1 |
| Interaction | SULT1C2 interactions | 1.30e-06 | 19 | 213 | 5 | int:SULT1C2 | |
| Interaction | SULT4A1 interactions | 4.54e-06 | 24 | 213 | 5 | int:SULT4A1 | |
| Interaction | SULT1A3 interactions | 4.54e-06 | 24 | 213 | 5 | int:SULT1A3 | |
| Interaction | SIRT7 interactions | SF3A1 TUFM RBM25 HELZ UTP20 AFDN RRP7A GCN1 MVP VCP COL5A1 FXR2 MSH2 IPO4 ECPAS LRPPRC WASF2 AATF PARN HADHA MTREX RAI1 | 1.41e-05 | 744 | 213 | 22 | int:SIRT7 |
| Interaction | ZBTB7B interactions | MYO9B HOXC10 VILL MYPN MVP SMARCA5 TCN2 FXR2 POLG ELP3 NCOR2 RNF2 CEP170B CUX1 | 3.73e-05 | 366 | 213 | 14 | int:ZBTB7B |
| Interaction | SULT1A2 interactions | 4.15e-05 | 19 | 213 | 4 | int:SULT1A2 | |
| Cytoband | 11p12-p11 | 1.05e-06 | 5 | 218 | 3 | 11p12-p11 | |
| Cytoband | 16p12.1 | 2.25e-04 | 25 | 218 | 3 | 16p12.1 | |
| GeneFamily | Sulfotransferases, cytosolic | 4.09e-08 | 14 | 135 | 5 | 762 | |
| GeneFamily | Beta-gamma crystallin domain containing | 1.65e-04 | 3 | 135 | 2 | 1360 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 3.61e-04 | 19 | 135 | 3 | 832 | |
| GeneFamily | Ferlin family | 8.14e-04 | 6 | 135 | 2 | 828 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 1.13e-03 | 7 | 135 | 2 | 653 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.33e-03 | 161 | 135 | 6 | 593 | |
| GeneFamily | Gelsolin/villins | 1.50e-03 | 8 | 135 | 2 | 950 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.29e-03 | 40 | 135 | 3 | 321 | |
| GeneFamily | Phospholipases | 3.78e-03 | 42 | 135 | 3 | 467 | |
| GeneFamily | Dyneins, cytoplasmic | 4.09e-03 | 13 | 135 | 2 | 538 | |
| GeneFamily | ATP binding cassette subfamily A | 4.75e-03 | 14 | 135 | 2 | 805 | |
| GeneFamily | NADH:ubiquinone oxidoreductase core subunits | 4.75e-03 | 14 | 135 | 2 | 1149 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 1.53e-06 | 68 | 217 | 7 | MM770 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | ERBB2 ERAP1 SPEG SYNPO NR4A1 PTGS2 ABCA8 DHH NOMO2 COL5A1 NR4A2 NOMO1 NOMO3 FILIP1L | 1.75e-06 | 355 | 217 | 14 | M45758 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | MYO9B IRF7 QRICH1 PARVG SULT1A2 GSE1 SULT1A1 SULT1A3 AP1G2 KATNIP REC8 RHBDF2 SLC2A8 POLG EBLN2 DVL3 PITPNM1 PIGQ TUBGCP6 SULT1A4 CUX1 MAN1B1 RAI1 | 2.02e-06 | 905 | 217 | 23 | M40865 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYO9B GSE1 ARHGEF7 GLRB HELZ UTP20 KIF5C SUCO WASF1 SMARCA5 DDR2 MSH2 TRAPPC8 NCOR2 LRPPRC RNF2 PARN MTREX MAP2K1 ATP2B1 CUX1 FILIP1L | 2.85e-06 | 856 | 217 | 22 | M4500 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | IRF7 PTPRS AP1G2 AFDN GCN1 SYT13 ZNF316 NBEA CNKSR2 TUBGCP6 EDEM3 NCOR2 DIP2C | 2.40e-05 | 389 | 217 | 13 | M39102 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | RELN GINM1 CYP4A11 INSR NR4A1 ABCA8 HOXC10 VILL ARHGEF7 PLCB1 PLCL1 NAPSA PLA2G7 MPC2 TCN2 DDR2 NR4A2 DNAJB4 CLDN7 CLIC6 GUCY1A2 ADAMTS6 ATP2B1 CDH16 FILIP1L | 3.94e-06 | 905 | 211 | 25 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_1000 | RELN CYP4A11 ALDH1L1 TMEM171 HOXC10 VILL PLCB1 PLCL1 DEGS2 NAPSA PLA2G7 MPC2 TCN2 DDR2 CYP4A22 SGK2 GUCY1A2 CCDC149 ACMSD CDH16 FILIP1L | 3.44e-05 | 778 | 211 | 21 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_1000 |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 4.51e-07 | 192 | 217 | 9 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.71e-07 | 193 | 217 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.71e-07 | 193 | 217 | 9 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.92e-07 | 194 | 217 | 9 | 3211d89440a6f4a9b3d4cfb755890816944242ec | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.13e-07 | 195 | 217 | 9 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.83e-07 | 198 | 217 | 9 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 163 | 217 | 8 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 163 | 217 | 8 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.85e-06 | 169 | 217 | 8 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 177 | 217 | 8 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.83e-06 | 179 | 217 | 8 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.83e-06 | 179 | 217 | 8 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-06 | 185 | 217 | 8 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.24e-06 | 189 | 217 | 8 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-06 | 190 | 217 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 4.58e-06 | 191 | 217 | 8 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-06 | 191 | 217 | 8 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.58e-06 | 191 | 217 | 8 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.76e-06 | 192 | 217 | 8 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.76e-06 | 192 | 217 | 8 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-06 | 193 | 217 | 8 | 3038ed3e53d3367136fac5c9773cd5b7414f49d3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.94e-06 | 193 | 217 | 8 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 5.13e-06 | 194 | 217 | 8 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.33e-06 | 195 | 217 | 8 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 5.33e-06 | 195 | 217 | 8 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 195 | 217 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.33e-06 | 195 | 217 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-06 | 195 | 217 | 8 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 195 | 217 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 5.33e-06 | 195 | 217 | 8 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 197 | 217 | 8 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | ASK440-Epithelial-Type_1|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.75e-06 | 197 | 217 | 8 | 1eda2c2504451a3d626dda5c2b2b12eeaa6bca54 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.75e-06 | 197 | 217 | 8 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-06 | 197 | 217 | 8 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.96e-06 | 198 | 217 | 8 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.96e-06 | 198 | 217 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-06 | 198 | 217 | 8 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 5.96e-06 | 198 | 217 | 8 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.96e-06 | 198 | 217 | 8 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.19e-06 | 199 | 217 | 8 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-06 | 200 | 217 | 8 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-06 | 200 | 217 | 8 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-06 | 200 | 217 | 8 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.42e-06 | 200 | 217 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.42e-06 | 200 | 217 | 8 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 102 | 217 | 6 | 2c3622fc3cd62d9b7e185d0204cf7f03e7dde73c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 155 | 217 | 7 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-05 | 162 | 217 | 7 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-05 | 163 | 217 | 7 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-05 | 163 | 217 | 7 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-7|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.75e-05 | 166 | 217 | 7 | b545de32578047c9ca422354b8992f2d9c9e1cc7 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.82e-05 | 167 | 217 | 7 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-05 | 167 | 217 | 7 | 8fede587572d465cb63f7828141a574185bbb819 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.82e-05 | 167 | 217 | 7 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.89e-05 | 168 | 217 | 7 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 1.89e-05 | 168 | 217 | 7 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.96e-05 | 169 | 217 | 7 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.20e-05 | 172 | 217 | 7 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.28e-05 | 173 | 217 | 7 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-05 | 174 | 217 | 7 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-05 | 174 | 217 | 7 | 667035a11b68745fa8446d6c68214713be42710f | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-05 | 174 | 217 | 7 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.47e-05 | 118 | 217 | 6 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-05 | 176 | 217 | 7 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 176 | 217 | 7 | 8e89471f838ea81235256cc2470f1c12c9b75f8a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 176 | 217 | 7 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-05 | 179 | 217 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 2.84e-05 | 179 | 217 | 7 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.84e-05 | 179 | 217 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.94e-05 | 180 | 217 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.94e-05 | 180 | 217 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 181 | 217 | 7 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 182 | 217 | 7 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.15e-05 | 182 | 217 | 7 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 182 | 217 | 7 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.15e-05 | 182 | 217 | 7 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-05 | 182 | 217 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.15e-05 | 182 | 217 | 7 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 3.26e-05 | 183 | 217 | 7 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.26e-05 | 183 | 217 | 7 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.50e-05 | 185 | 217 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 186 | 217 | 7 | e52cf44989c57c433bf82e9fa13b4643e88f3577 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 186 | 217 | 7 | 4c0b59d845b79323e7a3287e7c4d249f5f322556 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.75e-05 | 187 | 217 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.75e-05 | 187 | 217 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 187 | 217 | 7 | ed69e7cbd6fb59363b0e26f24887fc49405397ce | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.88e-05 | 188 | 217 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 188 | 217 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 4.01e-05 | 189 | 217 | 7 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | Severe-MAIT|World / Disease group and Cell class | 4.14e-05 | 190 | 217 | 7 | 7a92e0d6a021be23125495927b8571e25c83204a | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 190 | 217 | 7 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | Severe-MAIT|Severe / Disease group and Cell class | 4.14e-05 | 190 | 217 | 7 | 1c063dc1b62d9f9912aaf8d0297555a6545f5550 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.14e-05 | 190 | 217 | 7 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.20e-05 | 79 | 217 | 5 | 239d34f40c3a96186231f3aabd41c4988af3f372 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.20e-05 | 79 | 217 | 5 | a60fcbb278ba629af922c53faf58e4d96c537b15 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.29e-05 | 191 | 217 | 7 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 191 | 217 | 7 | a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 217 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 192 | 217 | 7 | 7af2b5240b1fad2177d8022e5f4fc1fe9e8f03b5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 193 | 217 | 7 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| Drug | dopamine-4-O-sulfate | 2.75e-07 | 7 | 217 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 2.75e-07 | 7 | 217 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 2.75e-07 | 7 | 217 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 2.75e-07 | 7 | 217 | 4 | CID011953812 | |
| Drug | dopamine 3-O-sulfate | 5.45e-07 | 8 | 217 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 5.45e-07 | 8 | 217 | 4 | CID003037707 | |
| Drug | 2-iodophenol | 5.45e-07 | 8 | 217 | 4 | CID000010784 | |
| Drug | minoxidil sulphate | 3.42e-06 | 25 | 217 | 5 | CID000004202 | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; HL60; HT_HG-U133A | 4.11e-06 | 164 | 217 | 10 | 6149_UP | |
| Drug | 1m2q | 4.20e-06 | 26 | 217 | 5 | CID005326637 | |
| Drug | EM-139 | 5.36e-06 | 13 | 217 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 7.45e-06 | 14 | 217 | 4 | CID000020908 | |
| Drug | deoxoestrone | 7.45e-06 | 14 | 217 | 4 | CID000005888 | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; HL60; HT_HG-U133A | MCL1 ALDH1L1 NR4A1 UBE2L3 AK2 TAC3 NR4A2 DNAJB4 DNAI4 CEP170B | 8.50e-06 | 178 | 217 | 10 | 1321_UP |
| Drug | arylsulfate | 1.01e-05 | 15 | 217 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 1.01e-05 | 15 | 217 | 4 | CID000002895 | |
| Drug | 2-naphthylamine | 1.07e-05 | 110 | 217 | 8 | CID000007057 | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 1.14e-05 | 184 | 217 | 10 | 2696_UP | |
| Drug | A-44 | 1.34e-05 | 16 | 217 | 4 | CID000120353 | |
| Drug | Domperidone maleate; Up 200; 7.4uM; PC3; HT_HG-U133A | ERAP1 SPEG ALDH1L1 PTGS2 TP53TG5 AMOTL2 COL5A1 NR4A2 SGK2 GUCY1A2 | 1.57e-05 | 191 | 217 | 10 | 4640_UP |
| Drug | benzilic acid | 1.73e-05 | 17 | 217 | 4 | CID000006463 | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | ERAP1 HOXC10 CRYBG1 KATNIP PLXNB1 DBF4B ECPAS PIGQ EDEM3 RNF2 | 1.80e-05 | 194 | 217 | 10 | 3807_DN |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; HL60; HG-U133A | 1.97e-05 | 196 | 217 | 10 | 2031_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; HL60; HT_HG-U133A | ABCA1 ERAP1 SYNPO AFDN SULT4A1 RHBDF2 DYNC2H1 SGK2 DYNC2LI1 CEP170B | 2.05e-05 | 197 | 217 | 10 | 3011_UP |
| Drug | 4-hydroxyestrone | 2.07e-05 | 59 | 217 | 6 | CID000018418 | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | ALDH1L1 AKT2 KIF5C NR4A2 SGK2 NCOR2 DNAH17 VPS41 MCOLN3 FILIP1L | 2.15e-05 | 198 | 217 | 10 | 4529_UP |
| Drug | 4-(1H-imidazol-1-yl)retinoic acid | 2.21e-05 | 18 | 217 | 4 | ctd:C496751 | |
| Drug | Atracurium besylate [64228-81-5]; Up 200; 3.2uM; MCF7; HT_HG-U133A | CAPN9 CEP104 ZNF862 ALDH1L1 AP1G2 CACNA1H PLXNB1 DNAJB4 PITPNM1 PIGQ | 2.24e-05 | 199 | 217 | 10 | 7477_UP |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; HL60; HT_HG-U133A | MYO9B ZNF862 AP1G2 NR4A2 IDS PALS1 DNAH17 VPS41 SMARCD3 CEP170B | 2.34e-05 | 200 | 217 | 10 | 2167_UP |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | CAPN9 ATAD5 ZNF862 NR4A1 ARHGEF7 PTPRS AKT2 PLCB3 LAMA3 PIGQ | 2.34e-05 | 200 | 217 | 10 | 6005_DN |
| Drug | mefenamic acid | 2.55e-05 | 37 | 217 | 5 | CID000004044 | |
| Drug | AC1Q6OHG | 2.78e-05 | 19 | 217 | 4 | CID000115063 | |
| Drug | pedunculagin | 2.78e-05 | 19 | 217 | 4 | CID000442688 | |
| Drug | Oleylethanolamide | 2.91e-05 | 7 | 217 | 3 | ctd:C440229 | |
| Drug | Phosphoadenosine Phosphosulfate | 2.91e-05 | 7 | 217 | 3 | ctd:D010724 | |
| Drug | PLP-Glu | 3.45e-05 | 20 | 217 | 4 | CID000444293 | |
| Drug | AC1L3PKS | 3.77e-05 | 96 | 217 | 7 | CID000093138 | |
| Drug | N-hydroxy-2-aminofluorene | 4.23e-05 | 21 | 217 | 4 | CID000005895 | |
| Drug | d-equilenin | 4.26e-05 | 41 | 217 | 5 | CID000010597 | |
| Drug | N-hydroxy-4-aminobiphenyl | 4.62e-05 | 8 | 217 | 3 | ctd:C014593 | |
| Drug | MeA alpha C | 5.13e-05 | 22 | 217 | 4 | CID000062244 | |
| Drug | AABSSN | 5.13e-05 | 22 | 217 | 4 | CID005464134 | |
| Drug | taselin | 6.16e-05 | 23 | 217 | 4 | CID000023846 | |
| Drug | 1IIg | 6.73e-05 | 45 | 217 | 5 | CID000001682 | |
| Drug | AalphaC | 7.34e-05 | 24 | 217 | 4 | CID000062805 | |
| Drug | AC1L3JHX | 8.18e-05 | 146 | 217 | 8 | CID000090206 | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; HL60; HG-U133A | 8.39e-05 | 188 | 217 | 9 | 2000_UP | |
| Drug | AzMC | 8.68e-05 | 25 | 217 | 4 | CID000064986 | |
| Drug | 2-pentanone | 8.68e-05 | 25 | 217 | 4 | CID000007895 | |
| Drug | TAK 733 | 9.04e-05 | 2 | 217 | 2 | ctd:C558666 | |
| Drug | Hydroxytryptophol | 9.04e-05 | 2 | 217 | 2 | ctd:D006917 | |
| Drug | 5-hydroxymethylfurfural | 9.04e-05 | 2 | 217 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 9.04e-05 | 2 | 217 | 2 | ctd:C012365 | |
| Drug | N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | 9.04e-05 | 2 | 217 | 2 | ctd:C544830 | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | 9.86e-05 | 192 | 217 | 9 | 3087_UP | |
| Drug | benzyloxyresorufin | 1.01e-04 | 78 | 217 | 6 | CID000114982 | |
| Drug | alpha-methyldopamine | 1.02e-04 | 26 | 217 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 1.02e-04 | 26 | 217 | 4 | CID000115245 | |
| Drug | MEK1/2 inhibitor | 1.03e-04 | 193 | 217 | 9 | CID009549284 | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.03e-04 | 193 | 217 | 9 | 5584_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.11e-04 | 195 | 217 | 9 | 7219_UP | |
| Drug | Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.11e-04 | 195 | 217 | 9 | 1293_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 195 | 217 | 9 | 7034_UP | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.15e-04 | 196 | 217 | 9 | 1843_DN | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; HL60; HT_HG-U133A | 1.15e-04 | 196 | 217 | 9 | 3108_UP | |
| Drug | LY 294002; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.15e-04 | 196 | 217 | 9 | 1216_DN | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 1.20e-04 | 197 | 217 | 9 | 4556_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | RELN ZNF862 NR4A1 PLCB3 EBLN2 PITPNM1 DNAH17 SMARCD3 FILIP1L | 1.20e-04 | 197 | 217 | 9 | 3848_DN |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.20e-04 | 197 | 217 | 9 | 1677_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.20e-04 | 197 | 217 | 9 | 5815_DN | |
| Drug | Triamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.20e-04 | 197 | 217 | 9 | 6010_UP | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.20e-04 | 197 | 217 | 9 | 2180_DN | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; HL60; HT_HG-U133A | ERBB2 ZNF862 ALDH1L1 AP1G2 RHBDF2 NR4A2 DYNC2LI1 USP6NL CEP170B | 1.25e-04 | 198 | 217 | 9 | 2155_UP |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; PC3; HT_HG-U133A | B3GALT2 HOXC10 SULT4A1 SYT13 TBC1D30 CNKSR2 PIGQ DNAH17 DNAI4 | 1.25e-04 | 198 | 217 | 9 | 4650_UP |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 217 | 9 | 1493_UP | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.25e-04 | 198 | 217 | 9 | 6341_DN | |
| Drug | prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 217 | 9 | 6590_UP | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; HL60; HT_HG-U133A | 1.25e-04 | 198 | 217 | 9 | 3112_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.25e-04 | 198 | 217 | 9 | 2578_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | EXT2 ARHGEF7 PTPRS PLCB1 CACNA1H CRYBG2 DYNC2H1 SMARCD3 USP6NL | 1.25e-04 | 198 | 217 | 9 | 3883_DN |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 217 | 9 | 1534_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.25e-04 | 198 | 217 | 9 | 7270_DN | |
| Drug | Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.25e-04 | 198 | 217 | 9 | 6307_DN | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 217 | 9 | 2273_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 217 | 9 | 1633_UP | |
| Drug | phorbolol myristate acetate | 1.33e-04 | 11 | 217 | 3 | ctd:C016658 | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; HL60; HT_HG-U133A | 1.36e-04 | 157 | 217 | 8 | 1304_UP | |
| Drug | AC1L1G9E | 1.37e-04 | 28 | 217 | 4 | CID000003586 | |
| Drug | Glu-P-2 | 1.58e-04 | 29 | 217 | 4 | CID000049970 | |
| Drug | minoxidil | 1.62e-04 | 54 | 217 | 5 | CID000004201 | |
| Drug | BB D | 1.62e-04 | 54 | 217 | 5 | CID000096840 | |
| Drug | phenacetin | 1.77e-04 | 55 | 217 | 5 | CID000004754 | |
| Drug | MeIQx | 1.77e-04 | 55 | 217 | 5 | CID000062275 | |
| Drug | 3,3'-T2 | 1.81e-04 | 30 | 217 | 4 | CID000065559 | |
| Drug | PtdIns(3,4)P | 1.86e-04 | 87 | 217 | 6 | CID000643960 | |
| Drug | vanadyl | ACP2 RPS6KB2 INSR PTPRS DNAH3 DNAH17 ACMSD MAP2K1 MAP2K2 ATP2B1 CUX1 | 1.87e-04 | 307 | 217 | 11 | CID000061671 |
| Drug | A2'p5'A2'p5'A | 2.06e-04 | 31 | 217 | 4 | CID000122642 | |
| Drug | barium hydroxide | 2.06e-04 | 31 | 217 | 4 | CID000028387 | |
| Drug | acetaminophen sulfate | 2.06e-04 | 31 | 217 | 4 | CID000083939 | |
| Drug | diphenylarsinic acid | 2.06e-04 | 31 | 217 | 4 | ctd:C493087 | |
| Disease | Colorectal Carcinoma | ABCA1 SF3A1 ALDH1L1 PTGS2 ABCA8 GSE1 PTPRS NLRP8 DNAH3 TCN2 RBP3 NR4A2 CNKSR2 MSH2 RET GUCY1A2 DIP2C DMRTA1 CUX1 | 7.59e-07 | 702 | 210 | 19 | C0009402 |
| Disease | Major Depressive Disorder | RELN IRF7 NR4A1 DTNBP1 PTGS2 PLCB1 NR4A2 FREM3 EDEM1 MAP2K1 CUX1 | 1.50e-06 | 243 | 210 | 11 | C1269683 |
| Disease | melanoma | PTGS2 ADAMTS20 CRYBG1 REC8 RET MAP2K1 MAP2K2 USP6NL CUX1 RAI1 CDK4 | 1.83e-06 | 248 | 210 | 11 | C0025202 |
| Disease | Malignant neoplasm of breast | ERBB2 RPS6KB2 LRRC37A2 PTGS2 NDUFS3 NAA25 LRRC37A SULT1A1 PLCB1 UTP20 AKT2 PLXNB1 NLRP8 DYNC2H1 NOA1 DVL3 PPHLN1 TRAPPC8 ELP3 SHROOM2 GUCY1A2 DIP2C CUX1 | 2.81e-06 | 1074 | 210 | 23 | C0006142 |
| Disease | Cutaneous Melanoma | 1.06e-05 | 41 | 210 | 5 | C0151779 | |
| Disease | Unipolar Depression | 1.82e-05 | 259 | 210 | 10 | C0041696 | |
| Disease | Malignant Neoplasms | 3.82e-05 | 128 | 210 | 7 | C0006826 | |
| Disease | Cardiomyopathies | 4.22e-05 | 130 | 210 | 7 | C0878544 | |
| Disease | Leukoplakia, Oral | 5.04e-05 | 2 | 210 | 2 | C0023532 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 5.15e-05 | 29 | 210 | 4 | C0496920 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.80e-05 | 239 | 210 | 9 | EFO_0008317, EFO_0020945 | |
| Disease | Ovarian Carcinoma | 5.91e-05 | 30 | 210 | 4 | C0029925 | |
| Disease | Adenocarcinoma of large intestine | 6.58e-05 | 96 | 210 | 6 | C1319315 | |
| Disease | hypertension | 7.62e-05 | 307 | 210 | 10 | EFO_0000537 | |
| Disease | shoulder impingement syndrome | 1.23e-04 | 36 | 210 | 4 | EFO_1001178 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.27e-04 | 108 | 210 | 6 | DOID:684 (biomarker_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 1.39e-04 | 268 | 210 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | small intestine adenocarcinoma (is_implicated_in) | 1.51e-04 | 3 | 210 | 2 | DOID:4906 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 1.63e-04 | 215 | 210 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 1.65e-04 | 72 | 210 | 5 | DOID:10534 (is_implicated_in) | |
| Disease | urinary bladder cancer (is_implicated_in) | 2.13e-04 | 76 | 210 | 5 | DOID:11054 (is_implicated_in) | |
| Disease | renal cell carcinoma (is_marker_for) | 3.19e-04 | 128 | 210 | 6 | DOID:4450 (is_marker_for) | |
| Disease | Leigh Disease | 3.50e-04 | 47 | 210 | 4 | C0023264 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 4.11e-04 | 49 | 210 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Mitochondrial Diseases | 4.11e-04 | 49 | 210 | 4 | C0751651 | |
| Disease | 2-hydroxysebacate measurement | 4.97e-04 | 5 | 210 | 2 | EFO_0800571 | |
| Disease | Involutional paraphrenia | 7.28e-04 | 25 | 210 | 3 | C1571983 | |
| Disease | Psychosis, Involutional | 7.28e-04 | 25 | 210 | 3 | C1571984 | |
| Disease | Involutional Depression | 7.28e-04 | 25 | 210 | 3 | C0011574 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 7.42e-04 | 6 | 210 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | X-14939 measurement | 7.42e-04 | 6 | 210 | 2 | EFO_0800747 | |
| Disease | Calcium channel blocker use measurement | 8.69e-04 | 213 | 210 | 7 | EFO_0009930 | |
| Disease | Colorectal Neoplasms | 8.75e-04 | 277 | 210 | 8 | C0009404 | |
| Disease | tyrosine measurement | 9.05e-04 | 104 | 210 | 5 | EFO_0005058 | |
| Disease | comparative body size at age 10, self-reported | RELN LRRC37A2 NDUFS3 TTBK1 GCN1 DNAJB4 PPHLN1 CNKSR2 ELP3 EDEM3 | 9.13e-04 | 420 | 210 | 10 | EFO_0009819 |
| Disease | hypertension, COVID-19 | 9.16e-04 | 27 | 210 | 3 | EFO_0000537, MONDO_0100096 | |
| Disease | osteoarthritis (is_implicated_in) | 1.02e-03 | 28 | 210 | 3 | DOID:8398 (is_implicated_in) | |
| Disease | asphyxiating thoracic dystrophy (is_implicated_in) | 1.03e-03 | 7 | 210 | 2 | DOID:0050592 (is_implicated_in) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.03e-03 | 7 | 210 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | 21-hydroxypregnenolone disulfate measurement | 1.03e-03 | 7 | 210 | 2 | EFO_0800281 | |
| Disease | HbA1c measurement | CEP104 MYO9B NAA25 FDPS MYPN PLCB1 PLCB3 FREM3 DYNC2LI1 HACL1 DMRTA1 GPSM1 RAI1 | 1.17e-03 | 675 | 210 | 13 | EFO_0004541 |
| Disease | Carcinoma, Ovarian Epithelial | 1.25e-03 | 30 | 210 | 3 | C4721610 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.37e-03 | 169 | 210 | 6 | DOID:3908 (is_marker_for) | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 1.37e-03 | 8 | 210 | 2 | DOID:5520 (is_marker_for) | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.38e-03 | 31 | 210 | 3 | C1335167 | |
| Disease | fatty liver disease (implicated_via_orthology) | 1.38e-03 | 31 | 210 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | schizophrenia (implicated_via_orthology) | 1.42e-03 | 68 | 210 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | ERBB2 RPS6KB2 LRRC37A2 PTGS2 NDUFS3 LRRC37A SULT1A1 AKT2 DYNC2H1 ELP3 GUCY1A2 | 1.44e-03 | 525 | 210 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | ERBB2 RPS6KB2 LRRC37A2 PTGS2 NDUFS3 LRRC37A SULT1A1 AKT2 DYNC2H1 ELP3 GUCY1A2 | 1.44e-03 | 525 | 210 | 11 | C1257931 |
| Disease | Mammary Neoplasms | ERBB2 RPS6KB2 LRRC37A2 PTGS2 NDUFS3 LRRC37A SULT1A1 AKT2 DYNC2H1 ELP3 GUCY1A2 | 1.48e-03 | 527 | 210 | 11 | C1458155 |
| Disease | prostate cancer (is_implicated_in) | 1.53e-03 | 117 | 210 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.67e-03 | 71 | 210 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.67e-03 | 71 | 210 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | Breast Carcinoma | ERBB2 RPS6KB2 LRRC37A2 PTGS2 NDUFS3 LRRC37A SULT1A1 AKT2 DYNC2H1 ELP3 GUCY1A2 | 1.74e-03 | 538 | 210 | 11 | C0678222 |
| Disease | anemia (phenotype), response to ribavirin | 1.76e-03 | 9 | 210 | 2 | EFO_0004272, GO_1901559 | |
| Disease | Leigh disease (is_implicated_in) | 1.76e-03 | 9 | 210 | 2 | DOID:3652 (is_implicated_in) | |
| Disease | RASopathy (implicated_via_orthology) | 1.76e-03 | 9 | 210 | 2 | DOID:0080690 (implicated_via_orthology) | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.76e-03 | 9 | 210 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | Parkinsonism (biomarker_via_orthology) | 1.81e-03 | 34 | 210 | 3 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | nephroblastoma (is_marker_for) | 1.81e-03 | 34 | 210 | 3 | DOID:2154 (is_marker_for) | |
| Disease | lung cancer (is_implicated_in) | 1.94e-03 | 74 | 210 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | cervix carcinoma (is_implicated_in) | 2.18e-03 | 10 | 210 | 2 | DOID:2893 (is_implicated_in) | |
| Disease | Optic Atrophy | 2.18e-03 | 10 | 210 | 2 | C0029124 | |
| Disease | cholate measurement | 2.18e-03 | 10 | 210 | 2 | EFO_0021509 | |
| Disease | coronary artery disease | ABCA1 MYO9B MCL1 QRICH1 ABCA8 NAA25 PLCL1 TBX20 WNK2 COL4A4 DYNC2H1 NOA1 PPHLN1 CNKSR2 GUCY1A2 GPSM1 ATP2B1 RAI1 | 2.32e-03 | 1194 | 210 | 18 | EFO_0001645 |
| Disease | Jeune thoracic dystrophy | 2.66e-03 | 11 | 210 | 2 | C0265275 | |
| Disease | Noonan Syndrome 1 | 2.66e-03 | 11 | 210 | 2 | C4551602 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 2.66e-03 | 11 | 210 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | Turner Syndrome, Male | 2.66e-03 | 11 | 210 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 2.66e-03 | 11 | 210 | 2 | C1527404 | |
| Disease | Mammary Ductal Carcinoma | 2.66e-03 | 11 | 210 | 2 | C0021367 | |
| Disease | Invasive Ductal Breast Carcinoma | 2.66e-03 | 11 | 210 | 2 | C1134719 | |
| Disease | Autistic Disorder | 2.76e-03 | 261 | 210 | 7 | C0004352 | |
| Disease | ovarian neoplasm | 2.77e-03 | 134 | 210 | 5 | C0919267 | |
| Disease | neuropsychological test | 2.96e-03 | 197 | 210 | 6 | EFO_0003926 | |
| Disease | Antihypertensive use measurement | 3.01e-03 | 265 | 210 | 7 | EFO_0009927 | |
| Disease | Malignant neoplasm of ovary | 3.04e-03 | 137 | 210 | 5 | C1140680 | |
| Disease | chronic kidney disease (implicated_via_orthology) | 3.17e-03 | 12 | 210 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | C-C motif chemokine 16 measurement | 3.17e-03 | 12 | 210 | 2 | EFO_0008044 | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 3.17e-03 | 12 | 210 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | Papilloma | 3.17e-03 | 12 | 210 | 2 | C0030354 | |
| Disease | Papillomatosis | 3.17e-03 | 12 | 210 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 3.17e-03 | 12 | 210 | 2 | C0205874 | |
| Disease | X-12707 measurement | 3.17e-03 | 12 | 210 | 2 | EFO_0800720 | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 3.33e-03 | 42 | 210 | 3 | DOID:8991 (is_marker_for) | |
| Disease | stomach cancer (is_marker_for) | 3.55e-03 | 142 | 210 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Short Rib-Polydactyly Syndrome | 3.73e-03 | 13 | 210 | 2 | C0036996 | |
| Disease | FVC change measurement, response to placebo | 3.73e-03 | 13 | 210 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | Carcinogenesis | 3.73e-03 | 13 | 210 | 2 | C0596263 | |
| Disease | ascorbic acid 3-sulfate measurement | 4.34e-03 | 14 | 210 | 2 | EFO_0800173 | |
| Disease | colonic neoplasm, overall survival | 4.34e-03 | 14 | 210 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | Saldino-Noonan Syndrome | 4.34e-03 | 14 | 210 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 4.34e-03 | 14 | 210 | 2 | C0024507 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 4.34e-03 | 14 | 210 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | phosphatidylcholine measurement | 4.39e-03 | 284 | 210 | 7 | EFO_0010226 | |
| Disease | disease progression measurement, Crohn's disease | 4.58e-03 | 47 | 210 | 3 | EFO_0000384, EFO_0008336 | |
| Disease | phosphoglycerides measurement | 4.86e-03 | 48 | 210 | 3 | EFO_0022291 | |
| Disease | low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor | 4.98e-03 | 15 | 210 | 2 | EFO_0004611, EFO_0005658 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 4.98e-03 | 15 | 210 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 5.15e-03 | 49 | 210 | 3 | DOID:0060037 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQPRALLKFPDIYGP | 71 | Q7L8C5 | |
| LLKFPDIYGPRPAVT | 76 | Q7L8C5 | |
| IGYKERPEAPDQTLP | 36 | P31751 | |
| PLKEGLKYSFPGERP | 1936 | Q68DN1 | |
| DPDLQLPFLLPEDGY | 926 | P55196 | |
| LYRLCPQPSKGEELP | 91 | Q9Y2J4 | |
| DRVFAPPKPSNILDY | 51 | Q96QE3 | |
| VLPKAQPGPEVRIYD | 761 | Q9Y5B0 | |
| KLPNPEEIPILRYVS | 576 | Q7L0X2 | |
| KPYDGIPAREIPDLL | 921 | P04626 | |
| EYIKDPNLPLLPTRN | 86 | O15467 | |
| PIFLDVKYGPDPVEI | 151 | Q6UY09 | |
| GQFRVYPELPKPSIS | 136 | P06731 | |
| YIRGAAPKDIPVPLS | 991 | Q14687 | |
| LIVPPFGKYPSLELQ | 1366 | O95477 | |
| PEVEKLLLQPSPYVR | 141 | O75843 | |
| PTLLVEPPDFCLYKG | 256 | P53420 | |
| IKEALRLYPPVPGIG | 376 | Q02928 | |
| DYPFPLGELEPGKLI | 291 | Q8TDX5 | |
| ERLLPGTIEKVYPEP | 46 | Q14155 | |
| YPERPKGPVQQDGEL | 191 | Q9Y4F5 | |
| FLEEKLAPPRYPKLG | 546 | Q96NY7 | |
| DGQETPYLVKLPLPA | 11 | Q92997 | |
| LRGPPLLLRAAEKYP | 51 | Q96SC8 | |
| PPTESLLLRKPYGRN | 906 | P20020 | |
| KPDEEIYNLPSELPG | 466 | P59510 | |
| NEPPKRDFLYPAVAP | 466 | Q9UKP5 | |
| FELLDYIVNEPPPKL | 311 | Q02750 | |
| AVGRYPIPPPDAKEL | 261 | P36507 | |
| PQPLPAGVAKYDENL | 131 | Q7Z5J4 | |
| QEKPYGRLLIQPGPR | 531 | O95072 | |
| APLIPYPLITKEDIN | 251 | P49756 | |
| REPITLQDPEAKYPL | 6 | Q6BCY4 | |
| PLYDKGDFILKIEPP | 81 | P69849 | |
| LYDLLQLPKGVEPPA | 6 | Q9HBI0 | |
| FRPQLDEPIPLYEAK | 316 | O95825 | |
| KDVQPRVTPLGYVLP | 586 | Q2TAL8 | |
| KINEIAVPGARYPLP | 141 | Q9Y5G5 | |
| ILHFGLPPRYQPDVK | 286 | Q9UJ83 | |
| PYLNLEGPDLQPKRD | 431 | O95453 | |
| EKLRPLYNHPAGPRT | 26 | O95563 | |
| QRIFYLKLEDLVPPP | 571 | P22736 | |
| PELGKPRQSPLTYED | 1531 | Q9Y618 | |
| PLYDKGDFILKIEPP | 81 | Q5JPE7 | |
| YPGSLPPELRVKSDE | 191 | O60309 | |
| PGEGRPQPELYCKLV | 71 | Q16787 | |
| YPGSLPPELRVKSDE | 191 | A6NM11 | |
| YPGSLPPELRVKSDE | 191 | A6NMS7 | |
| ELLKRVLNPLLPYGP | 181 | O60524 | |
| DVRLPPPADYNKEIT | 56 | P51116 | |
| LPNSGKYRLEDDPPV | 531 | Q8TDD5 | |
| EEYLPCLLLPKRPQG | 186 | Q86W28 | |
| NPYDIFLKDLEPPIV | 146 | Q16832 | |
| LPLPVRSRKYQEGPD | 446 | Q86YR5 | |
| PLPPAVFLGLARKIY | 401 | P14324 | |
| PVTAINLYPDGPEKR | 306 | Q9NU53 | |
| IKADPPDINILPAYG | 1011 | O60303 | |
| PDINILPAYGKDPRV | 1016 | O60303 | |
| PAAEPEYPKGIRAVL | 6 | P54819 | |
| PNDPLYAQSIREPLK | 536 | Q9BZQ6 | |
| NVYKRLIDVPDPVPA | 91 | Q13948 | |
| IPEPIKEATALFYGP | 471 | Q13948 | |
| PFPVPLVIIGSKYDV | 176 | Q8TCX1 | |
| GYPRLPVEKQCELAP | 106 | Q5VYK3 | |
| YPLPKQDLAAIPDFQ | 301 | Q9NZ08 | |
| YEKFLTPEEPFPLLG | 11 | Q6PEV8 | |
| DQLYKGVPLTQRPDP | 1786 | O43157 | |
| KINEIAVPGARYPLP | 141 | Q9Y5G4 | |
| RPFLENLIPKYLTPE | 256 | Q6P3R8 | |
| PRTVPFLPKYSAGLE | 36 | Q96EV8 | |
| GKNRQYPLDALEPQP | 81 | Q6P2I7 | |
| FTYKEAPGRPPELQL | 236 | Q8N819 | |
| PLYDKGDFILKIEPP | 81 | Q15155 | |
| PDVELRLPPLYGDNL | 121 | P54098 | |
| PALLVEKPRPDAIFG | 491 | P35354 | |
| SLLKYAGEPVPFIEP | 1361 | P42704 | |
| GPPQVLPRKRDYFLN | 121 | Q96RT7 | |
| SYDPRIRPNFKGIPV | 66 | P48167 | |
| QEKLYRPPPVLDALG | 1206 | Q92616 | |
| PDPFPLDVRKLLVAG | 51 | Q5VT99 | |
| SYVPVPEDGPFLKAL | 41 | Q9H0R1 | |
| KPFLLPVEAVYSVPG | 256 | P49411 | |
| YEPQLSPPDVKPGLR | 276 | Q05215 | |
| YLFLRKRQPDGPLGP | 976 | P06213 | |
| FPSPAELPDQKQLRY | 331 | Q92985 | |
| KTYVLNPLAPEFIPR | 1096 | P42694 | |
| PFPLYPGEVLEKDIT | 96 | Q14764 | |
| LYPQPGRRDVEVKPA | 576 | Q9UKM7 | |
| YSLAVEKLLNIRPPP | 151 | O75306 | |
| SPLRPGEKYPLVVFS | 136 | Q13093 | |
| KGVPDPRSQPVLLQY | 2236 | P78509 | |
| LPPVPAERNGAIVKY | 951 | Q13332 | |
| ILRSQIPPDRPYGKY | 51 | Q6ZMV5 | |
| RNSDLKPYIIFIAPP | 586 | Q8N3R9 | |
| KPYIIFIAPPSQERL | 591 | Q8N3R9 | |
| KSRPPGVPIYIKNLD | 296 | Q96DU9 | |
| LLKFPLGPCPRYEQL | 151 | P11117 | |
| ALLIEPLDKYPLAPG | 436 | Q01970 | |
| LLKPDLPPRHNYFTG | 266 | O43825 | |
| YLEPIFGRGALPKEQ | 1351 | Q8NCM8 | |
| RRIIGYGLPFPKNPD | 291 | Q9UDY4 | |
| KINAESLPYDERPLP | 371 | O60308 | |
| ASYVDPLGPQIERPK | 786 | Q13099 | |
| YRELIDGDPSLPPEK | 16 | Q6ZUS6 | |
| VPPQGLYDLPREPKD | 371 | Q99704 | |
| PASYIIGPEEDLPRK | 201 | Q8WUU5 | |
| LLAPGFQIPPNLDYK | 4121 | Q9UFH2 | |
| LFPGVVLPKPDYEVF | 1656 | Q8TD57 | |
| PAKEVYGAQPPIELL | 2146 | Q8TD57 | |
| VDQDLRTYLDKAPPP | 96 | P11802 | |
| ADIPVKGPLLFPEAR | 486 | Q8NFT6 | |
| DNEPPDYKSLIPLER | 806 | Q4L180 | |
| VPLLYKQFVPGVPER | 41 | O43323 | |
| YVFLGPARQPPKDRL | 801 | Q8NHY3 | |
| IKEALRLYPPVPGIG | 376 | Q5TCH4 | |
| PRDPLDILTKIFPNY | 326 | Q5VZB9 | |
| KPLFEDTPYILEPGE | 1121 | Q8N1P7 | |
| IPPIYGPLQELVRKG | 146 | A6NJJ6 | |
| SKLIGAYLPQPPRVD | 41 | Q9Y2E4 | |
| PSIPGYNLPLVRKIA | 266 | Q6QHC5 | |
| KPGPEDYPLFRGINL | 146 | P20908 | |
| ENPAFRPDGLKLYPT | 306 | Q9H9T3 | |
| QAPDVLFYPLRPELV | 481 | Q92611 | |
| DPKAAYRLEQPVGRP | 81 | Q9NYD6 | |
| AAYRQLPVLKEPEPE | 421 | Q5VTH9 | |
| GPGLKPPEERTIEYL | 226 | P40939 | |
| ISVPYGPIPVDFQRK | 281 | P22304 | |
| KLNPRPGKVVIYSEP | 1016 | Q9Y4K1 | |
| KVPLLVPGLNYPLET | 536 | Q8NFJ9 | |
| DPPEKRRGLYLTVPQ | 2316 | O95180 | |
| SDRFKLPPGEYILIP | 456 | O14815 | |
| DVAPYFKTEPGLPQI | 101 | Q7Z5N4 | |
| VENLGPKVQPYLPEL | 466 | Q8TEX9 | |
| PVPYVRPAILEKGQG | 616 | P43246 | |
| KKPPLLDRPGEGSYN | 36 | Q8NEY8 | |
| RPPLLPYIVNIKGQR | 656 | Q8NC60 | |
| RPDPNFDALISKIYP | 101 | Q99496 | |
| NFPLYLTKLPLPREG | 36 | O75309 | |
| LDGYEPEPLGKRPAV | 126 | Q07820 | |
| PPALNPIVYGVRTKE | 291 | Q8NGH5 | |
| DLLALYPGPDEKAPQ | 406 | Q01101 | |
| ELPDNFPKEIPGICY | 681 | P33402 | |
| QRIFYLKLEDLVPPP | 571 | P43354 | |
| PKYGRLVDAVGAPLP | 221 | P0C091 | |
| PVVKLADQDYEPPRL | 921 | Q2WGJ9 | |
| GLRPGLAEPYVKVQL | 271 | Q8NBV8 | |
| VPDGPLQEVPLRYLL | 711 | O75691 | |
| GTPEYLAPEVLRKEP | 196 | Q9HBY8 | |
| IYPLADLLARPLPEG | 2156 | O95425 | |
| ERYAKRKGLPPPLFS | 1611 | A0AVI2 | |
| IGQGKPYVFDRVLPP | 41 | O60282 | |
| IIRGKLALPPYLTPD | 281 | Q9UBS0 | |
| GYLPENGVLRPEPTK | 791 | Q8N3V7 | |
| ALLRQPGIYKPFIIG | 246 | Q9NY64 | |
| AFPVYRQPPESLKLE | 241 | O75489 | |
| PYPDPALKRETQAIL | 1766 | Q8NFP9 | |
| DAGYREPPQSPQKLL | 151 | Q8NET5 | |
| PYRLADKPTALQPRG | 506 | Q9BRB3 | |
| LDYQPPQFKLDPRLA | 256 | Q6STE5 | |
| ALPRKVQYRPVEGDP | 306 | Q6IA17 | |
| RPEYNAEPKLAAPGR | 281 | Q13796 | |
| AYPNRPDRPVLKGLT | 476 | Q03519 | |
| PLIDRYCGVKSPPLI | 116 | Q8NC67 | |
| RLDGNYLKPPIPLDL | 356 | P51888 | |
| RAYPLGDIPEDLVPL | 736 | Q8N3P4 | |
| PYPDDLVGFKLFLPE | 896 | Q15477 | |
| GIIYPPPEVRNIVDK | 41 | Q15459 | |
| DTSRPPLEYVKGVPL | 6 | P0DMN0 | |
| DTSRPPLEYVKGVPL | 6 | P0DMM9 | |
| PNTPLLQGIADYRPK | 401 | P20062 | |
| KILPNEYGHRRPPLF | 421 | O94911 | |
| VYRVLGKPEPAAQPV | 416 | Q9NY61 | |
| GKAPRLPQPEEGATY | 186 | O75891 | |
| PLIPTNIKYEFGPAI | 151 | O95471 | |
| GQPACDPRPREYLIK | 381 | Q8IUL8 | |
| PPAEPYIPRDEKGNL | 356 | Q8WXI2 | |
| RIPSPLGYAAIPIKF | 16 | Q9Y3A4 | |
| QPLTEGPRVIFIKPY | 176 | Q9Y2B4 | |
| PIPEPLVQLAVDKGY | 271 | Q9NUD9 | |
| IAPLTVPRYQKFPLG | 751 | O00562 | |
| FPYLEPLGAIPDVQK | 951 | Q15111 | |
| KLIIPPVDYLPDNRT | 721 | Q92738 | |
| PRAVPLSLPYQDFKR | 676 | Q5TCY1 | |
| PVKLRTYLGDPIPYD | 271 | Q96MH6 | |
| DEGPPVLLDKIYSRP | 1101 | P10745 | |
| LPAEEDYLPLKPRVG | 116 | P42285 | |
| PPQKPYTFLEEKARG | 2961 | Q15772 | |
| LPVLEYPQPGLDIIK | 86 | Q9BR01 | |
| YDIDPRNGIPKLTPG | 191 | Q496A3 | |
| PGRLDQLIYIPLPDE | 636 | P55072 | |
| AQLRDKEFYRPIPNP | 46 | Q96LM6 | |
| DTSRPPLEYVKGVPL | 6 | P50225 | |
| DISRPPLEYVKGVPL | 6 | P50226 | |
| DLPEKGPGPRQYFLL | 241 | Q93063 | |
| PFPFPQLAELREKYT | 516 | Q9Y2I9 | |
| LPSELPPRYEEKENA | 296 | Q8WVE6 | |
| PNDLYIVEPLKFSPE | 1091 | Q9UBS9 | |
| PLPKQEDAPVVYLGS | 121 | Q86YV5 | |
| QLKAISPYLPRGDPV | 441 | P49754 | |
| LKQRDPRLNEILYPP | 251 | Q9NQ66 | |
| QIAPSRKLLVPPYGA | 171 | Q9ULM0 | |
| LGGRAPYPSNKRLPE | 591 | O15195 | |
| PYPGIPPERLFNLLK | 951 | P07949 | |
| PPLNNLTPYRDDGKE | 131 | Q9Y6W5 | |
| GALYVEEPRTQKPPI | 1121 | O60290 | |
| IPEQSFYTKPLPGII | 511 | Q99805 | |
| SLGYPIPKPDLIFRL | 196 | A6NFI3 | |
| GLLYPPEAPELQIRK | 411 | Q9Y2L5 | |
| KYLPPELQPVNEGSL | 131 | Q6ZR37 | |
| YEDSQRPVPRPLNKL | 1226 | Q01118 | |
| VAGKADPPLPARLYV | 171 | Q9UMR3 | |
| PPPLNILTPYRDDGK | 131 | Q92558 | |
| IEALYRRLGKPLPPN | 1956 | Q9Y3S1 | |
| IGYKVPRNPELPNAA | 796 | O60264 | |
| DLLGKPPQLYDTPYE | 281 | Q5VZ18 | |
| ENVPSFGILKYPPRA | 106 | Q9UHF0 | |
| GVQIPLKEYGRAPVP | 331 | Q6PJF5 | |
| EDLYSRLGKQPPPGI | 1161 | Q96J92 | |
| GVLPAAEPKIYSLPR | 131 | P0DV77 | |
| PDNPPYDKGAFRIEI | 41 | P68036 | |
| AVIEYKGNCLPPLPL | 121 | Q9NRX2 | |
| LYKDPAGPSRVLLPV | 51 | Q5T447 | |
| PLEEDGQPPGAKRRY | 2126 | Q13459 | |
| EKDIQYPFLGPVPTR | 746 | Q14CX7 | |
| PGDKPIFVPLSNYRD | 61 | O96009 | |
| YEEPLGQPPRFTQKL | 261 | Q86TC9 |